Norman David Eansor - May 24, 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Stock symbol
MRKR
Transactions as of
May 24, 2022
Transactions value $
$0
Form type
4
Date filed
5/26/2022, 04:08 PM
Previous filing
Nov 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Stock Option (Right to Buy) Award $0 +80K $0.00 80K May 24, 2022 Common Stock 80K $0.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests on May 24, 2023, subject to the Reporting Person's continued service as a director through the vesting date.